Experimental manipulation of expression of MYOCD family genes has allowed the development of new animal models to study the mechanisms of DCM (MYOCD), cardiac hypertrophy, post-MI fibrosis (MRTF-A), and congenital heart disease (MRTF-B). This evidence concerns the gene MYOCD and familial dilated cardiomyopathy.